[go: up one dir, main page]

DE50106546D1 - PREPARATION OF CIMICIFUGA RACEMOSA FOR THE TREATMENT OF INCONTINENCE - Google Patents

PREPARATION OF CIMICIFUGA RACEMOSA FOR THE TREATMENT OF INCONTINENCE

Info

Publication number
DE50106546D1
DE50106546D1 DE50106546T DE50106546T DE50106546D1 DE 50106546 D1 DE50106546 D1 DE 50106546D1 DE 50106546 T DE50106546 T DE 50106546T DE 50106546 T DE50106546 T DE 50106546T DE 50106546 D1 DE50106546 D1 DE 50106546D1
Authority
DE
Germany
Prior art keywords
preparation
treatment
incontinence
cimicifuga racemosa
following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50106546T
Other languages
German (de)
Inventor
C Gessler
Thomas Nisslein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schaper und Bruemmer GmbH and Co KG
Original Assignee
Schaper und Bruemmer GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schaper und Bruemmer GmbH and Co KG filed Critical Schaper und Bruemmer GmbH and Co KG
Priority to DE50106546T priority Critical patent/DE50106546D1/en
Application granted granted Critical
Publication of DE50106546D1 publication Critical patent/DE50106546D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)

Abstract

A preparation of Cimicifuga racemosa can be used to successfully treat urinary incontinence in female mammals following an ovariohysterectomy. Positive results can also be expected for the treatment of women following a hysterectomy or after the menopause.
DE50106546T 2000-11-03 2001-10-12 PREPARATION OF CIMICIFUGA RACEMOSA FOR THE TREATMENT OF INCONTINENCE Expired - Lifetime DE50106546D1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE50106546T DE50106546D1 (en) 2000-11-03 2001-10-12 PREPARATION OF CIMICIFUGA RACEMOSA FOR THE TREATMENT OF INCONTINENCE

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10054641A DE10054641A1 (en) 2000-11-03 2000-11-03 Use of a preparation of Cimicifuga racemosa
PCT/DE2001/003926 WO2002036140A2 (en) 2000-11-03 2001-10-12 Use of a preparation of cimicifuga racemosa
DE50106546T DE50106546D1 (en) 2000-11-03 2001-10-12 PREPARATION OF CIMICIFUGA RACEMOSA FOR THE TREATMENT OF INCONTINENCE

Publications (1)

Publication Number Publication Date
DE50106546D1 true DE50106546D1 (en) 2005-07-21

Family

ID=7662102

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10054641A Withdrawn DE10054641A1 (en) 2000-11-03 2000-11-03 Use of a preparation of Cimicifuga racemosa
DE50106546T Expired - Lifetime DE50106546D1 (en) 2000-11-03 2001-10-12 PREPARATION OF CIMICIFUGA RACEMOSA FOR THE TREATMENT OF INCONTINENCE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10054641A Withdrawn DE10054641A1 (en) 2000-11-03 2000-11-03 Use of a preparation of Cimicifuga racemosa

Country Status (9)

Country Link
US (1) US6713097B2 (en)
EP (1) EP1330255B1 (en)
JP (1) JP2004512368A (en)
AT (1) ATE297747T1 (en)
AU (2) AU1814302A (en)
DE (2) DE10054641A1 (en)
ES (1) ES2240554T3 (en)
TW (1) TWI292319B (en)
WO (1) WO2002036140A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60119894D1 (en) 2000-01-20 2006-06-29 Eisai Co Ltd PIPERIDINE COMPOUNDS AND THESE MEDICAMENTS CONTAINING
DE10146159A1 (en) * 2001-09-19 2003-04-10 Bionorica Ag Use of extracts from Cimicifuga species as an organ-selective drug for the treatment of sex hormone-dependent diseases of the urogenital tract
US7060304B2 (en) * 2003-04-16 2006-06-13 Access Business Group International Llc Skin whitening compositions containing black cohosh extract
US6994874B2 (en) * 2003-04-16 2006-02-07 Access Business Group International, Llc Skin whitening compositions containing asparagus extract
EP2545932A1 (en) 2011-07-12 2013-01-16 Bionorica Se Selected cimicifuga fractions for treating osteoporosis
WO2013007807A1 (en) 2011-07-12 2013-01-17 Bionorica Se Selected cimicifuga fractions for the treatment of osteoporosis
EP2620155A1 (en) 2012-01-30 2013-07-31 Bionorica SE Medicine containing Cimicifuga for use in the treatment of sarcopenia and myocardial weakness
US20150313956A1 (en) * 2014-05-05 2015-11-05 Napier Consulting Llc Compositions and methods for hair growth

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652183C1 (en) * 1996-12-14 1998-02-12 Schaper & Bruemmer Gmbh Treating oestrogen-dependent tumour with Cimicifuga racemosa extract
DE19812204A1 (en) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Use of extracts from Cimicifuga racemosa and Belamcanda sinensis as an estrogen-like organ-selective drug without uterotropic effects

Also Published As

Publication number Publication date
WO2002036140A2 (en) 2002-05-10
US20030049340A1 (en) 2003-03-13
AU1814302A (en) 2002-05-15
EP1330255A2 (en) 2003-07-30
JP2004512368A (en) 2004-04-22
TWI292319B (en) 2008-01-11
AU2002218143B2 (en) 2005-07-21
EP1330255B1 (en) 2005-06-15
US6713097B2 (en) 2004-03-30
WO2002036140A3 (en) 2002-09-19
ES2240554T3 (en) 2005-10-16
DE10054641A1 (en) 2002-05-16
ATE297747T1 (en) 2005-07-15

Similar Documents

Publication Publication Date Title
ATE303156T1 (en) USE OF GNRH ANALOGUE TO TREAT URINARY INCONTINENCE
DE602005026638D1 (en) DEVICE TO TREAT ORGANIC INCIDENT IN THE FEMALE BASIN
IL138979A0 (en) Use of cannabinoids as anti-inflammatory agents
DE60122756D1 (en) DEVICE FOR TREATING FEMALE HARNINE CONTINENCE
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
NZ337211A (en) Method of treating inflammatory, HIV diseases by using peptidyl boronic acid ester and acid compounds as proteasome inhibitors
EP2377528A3 (en) Fatty acid metabolism inhibitors for use in the treatment of cancer
ATE333874T1 (en) CONJUGATED LINOLENIC ACID FOR THE TREATMENT OF CYCLOOXYGENASE-2 MEDIATED INFLAMMATION AND PAIN
ATE415962T1 (en) USE OF ASIATIC ACID OR ASIATICOSIDE TO TREAT CANCER
DE60032795D1 (en) NORDIHYDROGUAIARETINIC ACID DERIVATIVES FOR THE TREATMENT OF TUMORS
DE50106546D1 (en) PREPARATION OF CIMICIFUGA RACEMOSA FOR THE TREATMENT OF INCONTINENCE
TR200201250T2 (en) Hydroxyiecosatetraenoate salts, their compositions and methods for their use in the treatment of dry eye disorders.
WO2002015844A3 (en) Antimicrobial composition and methods of use in the treatment of disease
CY1106289T1 (en) USE OF PROGESTEPONE RECEPTOR INHIBITORS IN THE TREATMENT OF STEPID-RESISTANT BREAST CANCER
UY26474A1 (en) AMINO ACID DEPENDENT INHIBITORS FOR BRANCHED CHAIN AMINO ACIDS, AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY.
MXPA03010634A (en) Use of proteasome inhibitors to treat dry eye disorders.
EA199900091A1 (en) THERAPEUTIC APPLICATION OF T-BAM (CD40L) -TECHNOLOGY FOR THE TREATMENT OF DISEASES WITH PARTICIPATION OF SMOOTH MUSCLE CELLS
DE602004003173D1 (en) Use of conjugated linoleic acid for the treatment of the common cold
ATE302008T1 (en) TREATMENT OF INFLAMMATORY DISEASES
BR9915914A (en) Process for the cryo-conservation of plants
ATE291425T1 (en) R-ELIPRODIL FOR THE TREATMENT OF GLAUCOMA
DE50202941D1 (en) USE OF EXTRACTS FROM CIMICIFUGA SPECIES AS AN ORGANELECTIVE MEDICAMENT FOR THE TREATMENT OF SEXUAL-HORMONE-RELATED DISEASES OF THE UROGENITAL TRAIN
ATE530177T1 (en) ODORLESS FORMULATION FOR THE TREATMENT OF MUCOSA DISCONTINUITIES
DE60117685D1 (en) TOPICAL COMPOSITION AND METHOD FOR THE TREATMENT OF HARNINE CONTINENCE
ATE251460T1 (en) USE OF DANAZOLE TO TREAT HYPOGONADISM IN MEN

Legal Events

Date Code Title Description
8364 No opposition during term of opposition